Morphine Glucuronidation and Glucosidation Represent Complementary Metabolic Pathways That Are Both Catalyzed by UDP-Glucuronosyltransferase 2B7: Kinetic, Inhibition, and Molecular Modeling Studies

被引:52
作者
Chau, Nuy [1 ]
Elliot, David J. [1 ]
Lewis, Benjamin C. [1 ]
Burns, Kushari [1 ]
Johnston, Martin R. [2 ]
Mackenzie, Peter I. [1 ]
Miners, John O. [1 ]
机构
[1] Flinders Univ S Australia, Sch Med, Dept Clin Pharmacol, Adelaide, SA 5001, Australia
[2] Flinders Univ S Australia, Sch Chem & Phys Sci, Adelaide, SA 5001, Australia
基金
英国医学研究理事会;
关键词
HUMAN LIVER-MICROSOMES; IN-VIVO EXTRAPOLATION; ETA-RECEPTOR ANTAGONIST; DRUG-DRUG INTERACTIONS; BOVINE SERUM-ALBUMIN; ZIDOVUDINE GLUCURONIDATION; SUBSTRATE SELECTIVITY; ISOFORM SELECTIVITY; MYCOPHENOLIC-ACID; CRYSTAL-STRUCTURE;
D O I
10.1124/jpet.113.212258
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Morphine 3-beta-D-glucuronide (M3G) and morphine 6-beta-D-glucuronide (M6G) are the major metabolites of morphine in humans. More recently, morphine-3-beta-D-glucoside (M-3-glucoside) was identified in the urine of patients treated with morphine. Kinetic and inhibition studies using human liver microsomes (HLM) and recombinant UGTs as enzyme sources along with molecular modeling were used here to characterize the relationship between morphine glucuronidation and glucosidation. The M3G to M6G intrinsic clearance (CLint) ratio (similar to 5.5) from HLM supplemented with UDP-glucuronic acid (UDP-GlcUA) alone was consistent with the relative formation of these metabolites in humans. The mean CLint values observed for M-3-glucoside by incubations of HLM with UDP-glucose (UDP-Glc) as cofactor were approximately twice those for M6G formation. However, although the M3G-to-M6G CLint ratio remained close to 5.5 when human liver microsomal kinetic studies were performed in the presence of a 1: 1 mixture of cofactors, the mean CLint value for M-3-glucoside formation was less than that of M6G. Studies with UGT enzyme-selective inhibitors and recombinant UGT enzymes, along with effects of BSA on morphine glycosidation kinetics, were consistent with a major role of UGT2B7 in both morphine glucuronidation and glucosidation. Molecular modeling identified key amino acids involved in the binding of UDP-GlcUA and UDP-Glc to UGT2B7. Mutagenesis of these residues abolished morphine glucuronidation and glucosidation. Overall, the data indicate that morphine glucuronidation and glucosidation occur as complementary metabolic pathways catalyzed by a common enzyme (UGT2B7). Glucuronidation is the dominant metabolic pathway because the binding affinity of UDP-GlcUA to UGT2B7 is higher than that of UDP-Glc.
引用
收藏
页码:126 / 137
页数:12
相关论文
共 55 条
[1]   MECHANISM OF CADMIUM-DECREASED GLUCURONIDATION IN THE RAT [J].
ALARY, J ;
CRAVEDI, JP ;
BARADAT, M ;
CARRERA, G .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (11) :2139-2147
[2]   DIRECT DETERMINATION OF UDP-GLUCURONIC ACID IN CELL-EXTRACTS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
AW, TY ;
JONES, DP .
ANALYTICAL BIOCHEMISTRY, 1982, 127 (01) :32-36
[3]   SYNTHESIS OF MORPHINE-3-GLUCURONIDE [J].
BERRANG, B ;
TWINE, CE ;
HENNESSEE, GL ;
CARROLL, FI .
SYNTHETIC COMMUNICATIONS, 1975, 5 (03) :231-236
[4]   In vitro-in vivo correlations for drugs eliminated by glucuronidation:: Investigations with the model substrate zidovudine [J].
Boase, S ;
Miners, JO .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (05) :493-503
[5]   S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen [J].
Bowalgaha, K ;
Elliot, DJ ;
Mackenzie, PI ;
Knights, KM ;
Swedmark, S ;
Miners, JO .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (04) :423-433
[6]   Production of Ibuprofen Acyl Glucosides by Human UGT2B7 [J].
Buchheit, Daniela ;
Dragan, Calin-Aurel ;
Schmitt, Ellen I. ;
Bureik, Matthias .
DRUG METABOLISM AND DISPOSITION, 2011, 39 (12) :2174-2181
[7]   A novel metabolic pathway of morphine: formation of morphine glucosides in cancer patients [J].
Chen, XY ;
Zhao, LM ;
Zhong, DF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (06) :570-578
[8]  
Coffman BL, 1997, DRUG METAB DISPOS, V25, P1
[9]   Evaluation of 3′-azido-3′-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes:: Specificity and influence of the UGT2B7*2 polymorphism [J].
Court, MH ;
Krishnaswamy, S ;
Hao, Q ;
Duan, SX ;
Patten, CJ ;
Von Moltke, LL ;
Greenblatt, DJ .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (09) :1125-1133
[10]   COMPARISON IN DIFFERENT SPECIES OF BILIARY BILIRUBIN-IXALPHA CONJUGATES WITH ACTIVITIES OF HEPATIC AND RENAL BILIRUBIN-IXALPHA-URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASES [J].
FEVERY, J ;
VANDEVIJVER, M ;
MICHIELS, R ;
HEIRWEGH, KPM .
BIOCHEMICAL JOURNAL, 1977, 164 (03) :737-746